The Wound Management Innovation Cooperative Research Centre (WMI CRC) has been a catalyst for change in the wound industry since its inception in 2010. The WMI CRC is an industry led, cooperative organisation whose activities are transforming wound outcomes by addressing the key issues affecting wound healing and prevention. The WMI CRC brings together the best of industry, academia and end user organisations.
Transforming wound outcomes
We will improve wound healing and quality of life for people with wounds and implement cost effective wound care that lessens the burden on the Australian Health System
University of Western Australia
Curtin University of Technology
Metropolitan Health Service
Silver Chain Group
Queensland University of Technology
University of Queensland QFAB
Ego Pharmaceuticals Pty Ltd
Smith & Nephew Pty Ltd
Australian Wound Management Association Inc.
Department of Health Victoria
Royal District Nursing Service Limited
University of Melbourne
New South Wales
Southern Cross University
Mölnlycke Health Care
University of South Australia
Department of Health South Australia
Royal District Nursing Service SA
University of Tasmania
Jane is the former Deputy CEO of the Wound Management Innovation CRC and has extensive experience in the biotechnology industry. Prior to joining the WMI CRC, Jane worked as a private consultant to industry, academia and government on strategy, intellectual property, commercial feasibility, due diligence and new government initiatives. In 2004, Jane co-founded Implicit Bioscience Limited, where her role as Director of Corporate Strategy saw her involved in acquisitions, life cycle management, product extension strategies and management of the intellectual property portfolio. Jane has a PhD in the life sciences, Graduate Diploma in Applied Finance and Investment and venture capital experience at Gresham Rabo Management Limited and Queensland Investment Corporation.
Prof Harding, CBE FRCGP FRCP FRCS, has had a longstanding interest in wound healing. He has undergone training in both general surgery and general practice. He was appointed as the first Director of the Wound Healing Research Unit in 1991. From 2011 – 2013 he was Director of TIME Institute (Translation, Innovation, Methodology and Engagement) in the School of Medicine and Head of Wound Healing Research Unit, Cardiff University. In September 2013 he was appointed as Dean of Clinical Innovation at Cardiff University. His clinical practice is exclusively focused on treating patients with wound healing problems with a wide range of aetiologies. He has held external professorial appointments at universities in the UK and Australia. He has authored over 400 publications in the field of wound healing and has written a number of chapters and books in this area. He is the Editor-in-Chief of the International Wound Journal published by Wiley. He was the First President of the European Pressure Ulcer Advisory Panel, First Recorder of the European Wound Management Association and is a Past President of the European Tissue Repair Society. He was Chair of the International Working Group on Wound Healing in Diabetic Foot Disease, Chair of the Expert Working Group that produced a range of International Consensus Documents from 2004 – 2011. He has obtained funding of over £45 million from a range of academic, commercial and clinical sources since the Wound Healing Research Unit was created in 1991. He was awarded the CBE in the New Year Honours list in January 2013 for Services to Medicine and Health Care. In 2013 he was awarded £4.2 million to set up the Welsh Wound Innovation Initiative. The centre is designed to coordinate academic activity, both in terms of teaching and research, in addition to providing a coordinated approach to the care of patients with wounds. In 2014 he was elected to Fellowship of the Learned Society of Wales.
Douglas Queen. BSc, PhD, MBA, has been in the wound care arena for 30 years. Completed his PhD in Biomedical Engineering studying Wound Care Dressings in 1986 and his MBA in 1996. Initial career was with ConvaTec both in Research & Development and also Sales & Marketing. His experience included both Europe and North America.
Currently Douglas was previously Commercial Director, Welsh Wound Innovation Centre and Director, International Business & Strategic Development, Canadian Association of Wound Care (CAWC). He is Editor, International Wound Journal and publisher of Wound Care Canada and Diabetic Foot Canada eJournal.
Helen is Head of the School of Nursing at the Queensland University of Technology (QUT) in Queensland, Australia and a member of the Institute of Health and Biomedical Innovation. Professor Edwards is internationally recognised for her work in ageing, chronic disease and wound management. Her clinical research is focused on evaluating models of care for people with chronic wounds and self-management of chronic disease. She leads the wound management research team in the Faculty of Health at QUT and works with multi- disciplinary teams and in partnership with industry. Her team conducted the first clinical trial in Australia to demonstrate the effectiveness of a chronic disease self-management model of care for people with venous leg ulcers. Following this research several ‘Leg Clubs’ were set up across Australia including a Wound Healing Community Outreach Service at QUT which is in its fifth year of operation. In collaboration with Professor Zee Upton, Professor Edwards established the $110 million Wound Management Innovation Cooperative Research Centre. Professor Edwards is also involved in several research programs related to aged care and dementia and is the Director of the Queensland Dementia Training and Study Centre (Funded by Commonwealth Government) which is located at QUT.
Allison is an NHMRC Senior Research Fellow and Professor of Regenerative Medicine at the University of South Australia. Professor Cowin is a leading researcher in the area of wound healing and scar formation with over 60 peer-reviewed papers in top international journals. Professor Cowin heads a team of 12 staff and students who have established a world-leading and unique position in which to further define the mechanisms involved in wound healing particularly in relation to the role of the cytoskeletal protein Flii. Her team are developing new antibody-based therapies for the treatment of chronic wounds and burn injuries and her research has received special recognition from the NHMRC by inclusion in the 2008 ‘10 of the best projects’ publication. In 2009 she was awarded the MS McLeod Medal for Research Excellence.
Prof. Cowin has served on NHMRC peer review panels including the Inflammation GRP in 2007-2008 and acted as Deputy Chair in 2009. In 2012-13 she was a member of the Early Career Research Fellowships review panel. She is on the Editorial Advisory Board and acts as Associate Editor for the American Journal “Wound Repair and Regeneration”. Prof. Cowin is also the current Joint Editor of the Australian Journal: Wound Practice & Research. She is on the Scientific Advisory Board of The Australasian Blistering Diseases Foundation and an invited member of the international expert panel for the Wound Healing and Management node of the Joanna Briggs Institute which is developing new clinical guidelines to influence clinical practice within the wound community. Prof Cowin was the founder and inaugural President of the Australasian Wound & Tissue Repair Society (2007-2012) and was a member of the AWMA national committee (2007-2012)
Flavia is a molecular microbiologist, who received her PhD in Medical Microbiology from the University of Pretoria, South Africa and later received her post-graduate certificate in education from the University of Queensland. Flavia has achieved significant success in research outcomes that are evident by the number of publications, patents, technology transfers, and collaborations both with industry and government agencies. Since 2007, Flavia has also established a significant number of collaborations including Pathology Queensland, Queensland Health Forensic Science Services, Queensland Institute of Medical Research (QIMR), the Department of Natural Resources and Water Queensland, Universite Paris-Est Creteil France, University of Rosario, Colombia, and Immunexpress, USA.
Prof Gough has extensive experience in biomedical research and cancer biology, in the biotechnology industry, and in the Australian Cooperative Research Centres program. Inventor of technologies underpinning biopharmaceuticals and biotechnology products, marketed internationally and in clinical trials, including GM-CSF – one of the first pharmaceuticals based on Australian science and intellectual property. Key past appointments include: Head, Molecular Haematology Laboratory, The Walter and Eliza Hall Institute of Medical Research, Research Director AMRAD Corporation Limited, CEO Cerylid Biosciences Limited, CEO Cooperative Research Centre for Genes for Common Human Diseases, Director, Molecular and Genomic Discovery ES Cell International Pte Ltd (Singapore). Freelance biotechnology research and strategy consultant, operating at the interface of basic research and its commercial development or end-user engagement. Chairman and Principal Consultant, Nick Goug & Associates Pty Ltd Biotechnology and BioIndustries Consultants. Associate Professor (Honorary), Department of Medicine, University of Melbourne. External Scientific Advisor, Cancer Therapeutics Cooperative Research Centre. Recipient of the 2011 Clunies Ross Medal of the Australian Academy of Technological Sciences and Engineering for the application of science and technology for the benefit of Australia.
Nick is the Professor of Nursing Research, Translational Research at the University of Melbourne and the Royal Melbourne Hospital. He chairs the Skin Integrity Committee for Melbourne Health and was involved in establishing the Wounds West Project in WA. He has recently completed a large RCT investigating the effectiveness of silicone dressings in the prevention of pressure ulcers in critically ill ED/ICU patients. Other areas of Nick's research include the calculation of healing rate methods in diabetic foot wounds and venous leg ulcers and the investigation of the antimicrobial properties of electrolyzed water in infected wounds.
Professor Anne Gardner is Professor of Nursing at the School of Nursing, Midwifery and Paramedicine at the Australian Catholic University. Prof Gardner has an extensive health industry background in clinical nursing practice, post-registration education and clinical research. Her clinical interests are primarily in the areas of infection control and wound care. She has an international profile as a researcher into nurse practitioner competency standards and scope of practice, and is one of the four researchers on the recently completed nationally funded research project entitled “Reforming Healthcare: Nurse practitioners and workforce re-design”. Prof Gardner supervises several higher degree students including both PhD and Masters students.
Dr Steve Gower works for RMIT University in Melbourne as Director– Research Collaborations and Partnerships. Leading a small team, he is responsible for IP management, commercialisation of RMIT University research, research contracts as well as research partnerships with industry government and universities, both nationally and internationally; including Cooperative Research Centres. Previously he has held positions at the Australian Synchrotron, the Victorian
Department of Innovation, Industry and Regional Development, the Australian National University, the University of Wollongong and BHP Research. Dr Gower has a physics double major degree and a PhD in plasma physics and high power microwave engineering, the latter undertaken through the CRC program.
Dr Loveridge has been working with growth orientated businesses in the biotech and medtech industries for over 20 years. As an active venture investor he has established a lengthy track record of successful participation in European, US and Israeli-based healthcare companies. Based in Europe he also has considerable international experience at board level. Dr Loveridge’s current directorships include: Warambi Sarl; Corticrine Limited; JDS BioPharma Limited; Actinogen Medical Pty Ltd and Anaconda SAS.
Dr. Kishore Udipi received his Ph.D. in Polymer Science from the University of Akron and was a NASA postdoctoral fellow at Princeton. He has had over 30 years of successful industrial career at Phillips, Monsanto and Medtronic Cardiovascular. There he led projects in areas such as biomaterials, drug delivery, polymer blends, coatings, implantable polymers among others. He was a Senior Science Fellow at Monsanto, a position less than 1% of the scientists attain. At Medtronic, Dr. Udipi was Director of Polymer Research and Distinguished Scientist. He is the co-inventor of BioLinx® Polymer System employed in Resolute, one of the two leading drug eluting stents globally generating billions of dollars of revenue. He has 45 awarded US patents; and scores of awarded foreign patents. He has authored and co-authored book chapters and >40 papers in peer reviewed journals. He has made presentations and chaired sessions at national and international polymer and biomedical conferences.
A gold medalist from University of Bombay, Dr. Udipi was named a Distinguished Alumnus in 2013. He was inducted into the prestigious College of Fellows, American Institute of Medical and Biological Engineers and was awarded the Society for Biomaterials Technology, Innovation and Development Team Award, both in 2014.
Mark is the VP of Research and Technology at Smith and Nephew Wound Management in Hull, England and he has over 25 year’s experience in the Wound Management Sector within S&N bringing Innovative products to Global Markets. He has worked on Products as diverse as Allevyn , Dermagraft and NPWT. Mark has a first Degree in Microbiology a PhD in Biochemistry and an MBA. He is particularly interested in Open Innovation and the importance of fully understanding customer needs. At present his team are particularly focused on understanding the technology roadmap for meeting these clinical needs. He lives in York in the UK.
Chris is Managing Director and Founder of MediGroup EBI a successful SME medical device distribution and manufacturing business. Chris has a successful track record in the medical device and pharmaceutical industries with experience gained in the USA, UK, and Mainland Europe. His P&L, sales and marketing experience includes start-up phase, mid size growth and large corporate.
MediGroup EBI has focused on introducing ground breaking innovations into the medical device market. MediGroup's business unit, dedicated to launching advanced wound technologies, has introduced multiple wound market firsts into Australia: a gel based dressing, ultrasonic debridement, self-drying cross polymerized scar gels, multi-layer compression, dynamic tissue closure for abdominal reconstruction and other wounds, real time digital wound measurement, sub bandage compression measurement and truly portable unique dynamic compression, and many others.
Prior to MediGroup Chris established a peripheral vascular intervention business for Guidant (now Boston Scientific) in the UK, and went on to run their national cardiac intervention marketing in the UK, during his tenure market share more than doubled. He has successfully led the launch of 24 medical devices at the national level. Later, based in Belgium, he was an Associate Director for International Sales and Marketing Organization at AstraZeneca - a role that spanned all non-US sales and marketing and all therapeutic areas. In California, USA he advised medical device industry on the development of new products: R&D processes, organization and strategy. Clients included blue chip device companies.
Chris draws on these skills spanning R&D, through to commercial launches in devices and intimate knowledge of the woundcare market to contribute to the Wound CRC Development Advisory Committee.
Chris holds a Bachelors and Masters of Engineering from Cambridge University in the UK and an MBA, with distinction, from INSEAD, France.
Ian Landreth has had a successful history in leadership, and the growth and establishment of health organisations in both the profit and NFP sectors. Ian has previously delivered Consultancy services for eight years for many industry sectors, from small entrepreneurial start-ups, government departments to multi-nationals in both Australia, and New Zealand. Ian has worked extensively with business leaders facilitating strategic planning, executive coaching and mentoring, change management, business development, system realignment and quality improvement. Ian has delivered many workshops on personal and team development and trained managers in performance management of staff. Ian has worked with, and been published in, the area of Values-based recruitment and has been a speaker on many occasions across a wide sector of topics at regional, state and international conferences. Ian is trained and experienced in Corporate Governance with experience of Directorship and Company Secretary with responsibility in risk management and compliance over many years.
Corporate Services Manager
Emma is a commercial lawyer with more than 7 years' experience in private and government practice and as in-house counsel. Her breadth of business experience spans the not-for-profit and resource sectors in addition to her depth of experience in the legal arena.
Emma brings to the CRC many years of operational experience in corporate governance and business intelligence systems. These skills and years of experience will support the day to day operation for the CRC and support continuous improvement of the entire organisation.
Emma manages the corporate and legal operations of the CRC and supports the Chief Operating Officer in managing the CRC's administrative and staff resources.
Jessica commenced with the CRC in June 2016 as Executive Assistant. In addition to providing essential support to the Board and executive management, Jessica also oversees the administrative functions of the National Office. Jessica holds a Bachelor in Science and has a strong background as an executive level administrator with over 10 years experience in customer service, sales, logistics, and government regulation.
Project and Web Coordinator
Nytasha commenced with the CRC in June 2016 as a Project and Web Coordinator. With over 7 years’ experience delivering large e-Commerce website developments, her business experience spans from Project Management and Business Analysis, through to Workplace Training and Change Management. With a focus on building intuitive systems and streamlining manual procedures, Nytasha values creative and efficient design.
© Wound Management Innovation CRC 2017